Opiant in the news
Pharmaceutical Company Looks to Stop Heroin Addiction Before it Starts – Fox Business
October 26, 2017 – Opiant CEO Dr. Roger Crystal discusses the Company’s role in combating addiction and the opioid crisis, a “public health emergency” as declared by President Trump.
A Call to Washington from the Pharma Industry – an Op-ed by CEO Roger Crystal
October 6, 2017 – Opiant CEO Dr. Roger Crystal calls on Washington to partner with the pharma industry to tackle the opioid crisis.
Opioids, Doctors and Drug Addiction – KCRW Radio
September 29, 2017 – Opiant CEO Dr. Roger Crystal speaks with radio station KCRW about opioids, doctors and drug addiction.
Meeting of the President’s Commission on Combating Drug Addiction and Opioid Crisis
September 27, 2017 – Opiant CEO Dr. Roger Crystal testifies before the President’s Commission on Combating Drug Addiction and the Opioid Crisis.
Mother Who Lost Her Daughter to Opioid Crisis Speaks Out – Fox News
August 11, 2017 – Opiant CEO Dr. Roger Crystal discusses the opioid crisis being declared a national emergency by President Trump.
Opiant Pharmaceuticals Looks to Create a Heroin Vaccine and Treat Addictions – The Street
July 28, 2017 – Opiant Pharmaceuticals Inc. is best known today for its NARCAN® Nasal Spray used to treat opioid overdoses. But CEO Roger Crystal hopes to make overdoses a thing of the past for most addicts by developing a vaccine that can end heroin dependence.
NARCAN® Nasal Spray Creators Developing a ‘Heroin Vaccine’– Fox & Friends
July 27, 2017 – Opiant CEO Dr. Roger Crystal provides insight on ‘Fox & Friends’.
New Tool to Prevent Deaths from Opioid Overdoses – Fox Business Network’s “Mornings with Maria”
July 26, 2017 – Opiant CEO Dr. Roger Crystal on a new tool and efforts to battle the opioid crisis in America.
How a Nasal Spray can Save Lives from Opioid Overdoses – WTOP-DC Radio
July 15, 2017 – Phil Skolnick, Opiant’s Chief Scientific Officer, speaks with radio station WTOP-DC about Opiant’s intranasal naloxone.
NARCAN® Nasal Spray Inventor on U.S. Drug Epidemic – WSJ’s “Lunch Break”
September 15, 2016 – Opiant CEO Dr. Roger Crystal explains to The Wall Street Journal how NARCAN® Nasal Spray has been used to fight against opioid overdoses on the front line.